baber/WOPTO huggingface dataset:
Patent AU-2020206519-A1 (AU)
Title: Crystalline forms of 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide
Inventor: GEBHARDT JOACHIM
IPC: C07D403/12
Filed: 2020-01-10
Abstract: The present invention relates to a novel crystalline form of 1-(1,2-dimethylpropyl)- N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide recently assigned the common name dimpropyridaz. The invention also relates to the use of the crystalline form B for combating invertebrate pests and to formulations for plant protection which contain the crystalline form B of 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4- yl-pyrazole-4-carboxamide. The crystalline form B according to the present invention can be identified by powder X-ray diffractometry on the basis of its powder X-ray diffraction diagram, hereinafter also termed powder X-ray diffraction pattern or PXRD pattern,of the polymorph form B recorded using Cu-Kα radiation (1.54178 Å) at 25°C displays the 3 following reflections, quoted as 2θ values: 20.69±0.10°, 24.15±0.10°and 30.52± 0.10°.In addition to these 3 reflections, the polymorph B of the present invention may display in such a PXRD pattern one or more, in particular at least 2, often at least 4, in particular at least 6 or at least 8 reflections and especially all of the reflections quoted hereinafter as 2θ values:7.99±0.10°, 10.07±0.10°, 12.38±0.10°,15.31±0.10°, 15.97±0.10°, 16.50±0.10°, 18.03±0.10°,19.29±0.10°, 20.22±.0.10°, 20.96± 0.10°, 23.40±0.10°, 23.70±0.10°,26.09±0.10°, 27.26±0.10°and 32.91±0.10°.
Patent AU-2020218651-A1 (AU)
Title: Arginase inhibitors and methods of use thereof
Inventor: MLYNARSKI SCOTT NATHAN
IPC: A61K31/69
Filed: 2020-02-07
Abstract: Disclosed are compounds of formula (Ib) or (Vc), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (Ib) or (Vc) and methods of using the same for treating cancer, respiratory inflammatory disease, and inhibiting arginase; wherein R
Patent AU-2020218729-A1 (AU)
Title: Filtration media packs produced using additive manufacturing
Inventor: RODRIGUEZ JAVIER A
IPC: B33Y80/00
Filed: 2020-01-20
Abstract: A filter comprising: a housing defining a Cartesian coordinate system including an X-axis, a Y-axis, and a Z-axis; and a filter medium (800) including a plurality of layers of solidified material; wherein at least one (802) of the plurality of layers of solidified material includes an undulating strip (804) of solidified material extending in a first predetermined direction (806) forming a first angle (808) with the X- axis.
Patent AU-2020219393-A1 (AU)
Title: Pyrazole derivatives
Inventor: MORRIS JAMES ALAN
IPC: C07D207/34
Filed: 2020-02-04
Abstract: The present invention relates to pyrazole derivatives of formula (X) wherein ring A is a pyrazole and substituents R
Patent AU-2020250026-A1 (AU)
Title: Isothiazolidine 1,1-dioxide and 1,4-butan sultone containing rapamycin derivatives and uses thereof
Inventor: BONAZZI SIMONE
IPC: A61P9/12
Filed: 2020-03-25
Abstract: Described herein are compounds of Formula (I) that are inhibitors of mTORC1, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
Patent AU-2020250828-A1 (AU)
Title: Computer-implemented method and system for determining a relative risk for lack of glycemic control for a plurality of patients, and computer program product
Inventor: BIVEN RICHARD P
IPC: G16H50/30
Filed: 2020-03-27
Abstract: A computer-implemented method for determining a relative risk for lack of glycemic control for at least two patients is provided, comprising: providing a first set of glucose measurement data assigned to a first patient, the first set of glucose measurement data collected by conducting a first frequency of measurement events; providing a second set of glucose measurement data assigned to a second patient, the second set of glucose measurement data collected by conduct- ing a second frequency of measurement events which is different from the first frequency of measurement events; providing a plurality of evaluation parameters in the data storage device, each of the evaluation parameters assigned to at least one of the first frequency of measurement events and the second frequency of measurement events; determining, depending on the first frequency of measurement events, at least one first evaluation parameter from the plurality of evaluation parameters in the data storage device; determining, depending on the second frequency of measurement events, at least one second evaluation parameter which is different from the at least one first evaluation parameter from the plurality of evaluation parameters in the data storage device; determining a first evaluation parameter value assigned to the first patient for the at least a first evaluation parameter; determining a second evaluation parameter value as- signed to the second patient for the at least a second evaluation parameter which is different from the first evaluation parameter; determining a first risk score assigned to the first patient and a second risk score assigned to the second patient from the first evaluation parameter value and second evaluation parameter value, respectively; and determining a relative risk for lack of glycemic control by comparing a first total risk score comprising the first and a second total risk score comprising the second risk scores. Further, a system for determining a relative risk for lack of glycemic control for at least two patients and a computer program product are provided.
Patent AU-2020264437-A1 (AU)
Title: Carbon-carbon nanotube hybrid materials and methods of producing same
Inventor: PRADA SILVY RICARDO A
IPC: B82Y40/00
Filed: 2020-04-29
Abstract: Carbon-carbon nanotube (CNT) hybrid materials, and methods of producing the hybrid materials. The hybrid materials include carbon particles and CNTs on the surface of the particles. The CNT comprises more than about 3.2 weight percent of the hybrid material.
Patent AU-2020284220-A1 (AU)
Title: Rowing exercise machines having a configurable rowing feel
Inventor: SMITH BRUCE
IPC: A63B22/00
Filed: 2020-05-08
Abstract: Among other things, a rowing exercise machine includes a movable inertial element, an eddy current brake coupled to the movable inertial element, a rowing grip coupled to the movable inertial element, and control circuitry coupled to the eddy current brake to cause a resistance to motion of the rowing grip during part of a rowing stroke. The resistance to motion of the rowing grip during the drive phase of the rowing stroke conforms to a target feel for a rower. The target feel corresponds to a feel for a rower of a target other rowing exercise machine or other target feel of interest.
Patent AU-2020288605-A1 (AU)
Title: AAV vectors with myelin protein zero promoter and uses thereof for treating schwann cell-associated diseases like charcot-marie-tooth disease
Inventor: KLEOPA KLEOPAS
IPC: A61K48/00
Filed: 2020-06-03
Abstract: The present invention provides viral vectors for use in the treatment and prevention of diseases associated with Schwann cells by delivering polynucleotides specifically to Schwann cells and achieving Schwann cell specific expression. The present invention has particular application in treatment and prevention of Charcot-Marie-Tooth disease and other demyelinating neuropathies. The preferred vectors are adeno-associated vectors (AAV) having a Schwann cell-specific promoter from the Myelin Protein Zero (Mpz, P0) or a minimal Mpz promoter.
Patent AU-2020289525-A1 (AU)
Title: System and method for fabricating a cornea
Inventor: MOSS SARAH
IPC: A61F2/14
Filed: 2020-06-03
Abstract: A method for fabricating a cornea includes affixing a frame to at least one cell culture insert comprising a generally cylindrical structure having a proximal end and a distal end, a base disposed at the proximal end, and a porous membrane disposed between the proximal end and the distal end; affixing a dome-shaped member to the porous membrane within the frame, the dome-shaped member comprising a crown, a dome base, and a surface connecting the crown and the dome base; depositing a material comprising a matrix-forming compound on the frame such that the crown and at least a portion of the surface of the dome-shaped member is coated with the material comprising the matrix-forming compound; and removing the dome-shaped member to produce a fabricated cornea attached to the frame. A system for fabricating a cornea and a cornea scaffold are also described herein.
Patent AU-2020289992-A1 (AU)
Title: Method for operating a water-bearing household appliance and water-bearing household appliance
Inventor: SCHULTZ JAKOB
IPC: D06F39/02
Filed: 2020-06-08
Abstract: A method for operating a water-bearing household appliance (1) for treating articles, in particular a dishwasher or washing machine, the water-bearing household appliance (1) including a treatment chamber (4) for treating the articles with a washing liquor and a dosing system (20) for dispensing a dosing-amount of detergent provided by a dosing unit, the method comprising: Selecting (S1) one of a plurality of different treatment cycles, Controlling (S2) the water-bearing household appliance (1) to perform the selected treatment cycle, Actuating (S3) the dosing system (20) to dispense the dosing-amount of detergent according to the selected treatment cycle, Detecting (S4) a sensor signal (S) of the dispensed dosing-amount of detergent, Adjusting (S5) the selected treatment cycle as a function of the detected sensor signal (S), and Controlling (S6) the water-bearing household appliance (1) to perform the adjusted treatment cycle.
Patent AU-2020292699-A1 (AU)
Title: Stable wrapper for aerosol generating article
Inventor: JOYEUX THIERRY
IPC: D21H17/13
Filed: 2020-06-08
Abstract: A wrapper used in smoking articles. The wrapper has a low grease penetration or visual spotting and may be utilized with an aerosol generating substrate. The aerosol generating article (10) includes an aerosol generating substrate (12) comprising nicotine and a gel composition. The wrapper is disposed about and in contact with the aerosol generating substrate. The wrapper comprise a paper layer (50) comprising a surface treatment such that the paper has a negative result for at least one kit oil sample of method Tappi 559cm-02, classical method 2002.
Patent AU-2020300033-A1 (AU)
Title: Methods of treating HIV in pediatric patients with rilpivirine
Inventor: CRAUWELS HERTA
IPC: A61K31/7068
Filed: 2020-07-03
Abstract: The disclosure is directed to the use of rilpivirine, or a salt thereof, to treat HIV infection in pediatric subjects.
Patent AU-2020317848-A1 (AU)
Title: Support foot
Inventor: BIRCH SAM
IPC: F24F13/32
Filed: 2020-07-10
Abstract: A support foot for securing a frame member on a supporting surface, comprising a base portion having a base surface for resting on said supporting surface; a central portion connected to the base portion, and a core having opposed first and second ends and a longitudinal axis extending between the first and second ends and configured to receive a frame member. The core comprises at least one resiliently deformable member extending from a root at the first end to a free distal end in a direction substantially parallel to the longitudinal axis and spaced from an inner surface of the central portion, whereby to form a gap into which the at least one resiliently deformable member can deform. The at least one resiliently deformable member is configured to deflect into the gap and away from an associated opposed surface. The at least one resiliently deformable member comprises a first surface configured to apply a first force to an outer surface of the frame member towards the associated opposed surface when the frame member is inserted into the core, and the at least one resiliently deformable member is configured to secure the frame member against said opposed surface when the frame member is inserted into the core.
Patent AU-2020331910-A1 (AU)
Title: Sequential storage of collected data from heterogeneous intervals
Inventor: MARSH IVAN
IPC: G01D4/00
Filed: 2020-08-12
Abstract: A method performed by a node includes writing normal records to a buffer. Each normal record is associated with a respective time interval having a respective start time and end time according to network time, and each normal record includes respective collected data describing an activity. The method includes detecting that access to network time has become unavailable as well as detecting that access to network time has become available after having been unavailable. The method includes determining information describing an incomplete period during which network time was unavailable, where the incomplete period includes at least one of a skipped interval and a standby interval. During each skipped interval, no collected data describing the activity is collected. Each standby interval is associated with respective collected data describing the activity during the incomplete period. The method includes writing to the buffer a placeholder record including the information describing the incomplete period.
Patent AU-2020336975-A1 (AU)
Title: Perk inhibiting pyrrolopyrimidine compounds
Inventor: MULVIHILL MARK J
IPC: C07D487/04
Filed: 2020-08-28
Abstract: Provided herein are compounds of formula (I), compositions, and methods useful for inhibiting PERK and for treating related conditions diseases, and disorders.
Patent AU-2020344143-A1 (AU)
Title: Subsurface safety valve and method of operating a subsurface safety valve
Inventor: ACKROYD WARREN
IPC: E21B34/06
Filed: 2020-09-09
Abstract: A subsurface safety valve is provided. The subsurface safety valve comprises an assembly configured to convert rotary motion from an electrically controlled drive into linear motion of a member, the member configured to actuate a valve.
Patent AU-2020358002-A1 (AU)
Title: Combinations of GABA-A receptor positive allosteric modulators and NMDA antagonists, NMDA negative allosteric modulators or NMDA partial agonists
Inventor: LOYA CARLOS
IPC: A61K47/06
Filed: 2020-10-02
Abstract: The invention relates to combinations of GABA-A Receptor positive allosteric modulators and NMDA antagonists, NMDA Negative Allosteric Modulators or NMDA partial agonists and methods using such combinations to treat mood disorders, such as depression and anxiety.
Patent AU-2020371992-A1 (AU)
Title: Swellable antimicrobial fibre
Inventor: AGBOH CHRISTOPHER OCHAYI
IPC: A61L17/00
Filed: 2020-10-22
Abstract: A swellable biocompatible material and method of making the same. The material comprises a water-absorbing swellable polymer infused with povidone-iodine and water-soluble control compound configured to control a release of iodine form the material. Example swellable polymers includes polysaccharides and hydrocolloid forming compounds.
Patent AU-2020379319-A1 (AU)
Title: Use of veto cells in treatment of T cell mediated autoimmune diseases
Inventor: REISNER YAIR
IPC: A61P35/02
Filed: 2020-11-05
Abstract: A method of treating or preventing a T cell mediated autoimmune disease in a subject in need thereof is disclosed. The method comprising: (a) transplanting immature hematopoietic cells into the subject; and (b) administering to the subject a therapeutically effective amount of an isolated population of non-GVHD inducing anti-third party cells comprising cells having a central memory T -lymphocyte (Tcm) phenotype, the cells being tolerance inducing cells and capable of homing to the lymph nodes following transplantation.
Patent AU-2020388398-A1 (AU)
Title: Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug
Inventor: DANA ADRIAN
IPC: G06Q50/00
Filed: 2020-11-19
Abstract: Methods and systems for managing the distribution of a drug comprising a food allergen are described herein. Exemplary methods allow for the enrollment of distributors, pharmacies, healthcare settings, healthcare providers, and/or patients in a drug distribution management database for the drug, wherein distribution or provision of the drug is contingent on ensuring enrollment of one or more of the entities in the drug distribution management database. Other methods utilizing the drug distribution management database are also described.
Patent AU-2020396883-A1 (AU)
Title: Soccer trainer net
Inventor: HUTH RICHARD RAYMOND
IPC: A63B63/00
Filed: 2020-12-01
Abstract: A soccer training net includes a frame having an upper portion and a lower portion, a generally rectangular net having a bottom edge and a top edge, and a lower elastic member having a first end, a second end, and a medial section that extends between the ends. The medial section is coupled with and extends along the bottom edge of the net. Each end is coupled the lower portion of the frame. Upper coupling members extend between and are coupled with the upper portion of the frame and corners of the top edge of the net. The frame does not include a member that extends along the bottom edge of the net such that the medial section of the lower elastic member and the bottom edge of the net are suspended between the sides of the lower portion of the frame.
Patent AU-2020414376-A1 (AU)
Title: Treatment involving immune effector cells genetically modified to express antigen receptors
Inventor: BILLMEIER ARNE
IPC: A61K39/00
Filed: 2020-12-22
Abstract: The present disclosure relates to methods for enhancing the efficiency of therapies involving immune effector cells such as T cells engineered to express antigen receptors such as T cell receptors (TCRs) or chimeric antigen receptors (CARs). It is demonstrated herein that such antigen receptor-engineered immune effector cells, even when provided to a subject in sub-therapeutic amounts, are extremely effective in the treatment of cancer diseases, even those cancer diseases that are known to be difficult to treat with antigen receptor-engineered immune effector cells, such as solid tumors or cancers, if additionally target antigen for the antigen receptor is provided to the subject. Immune effector cells may be engineered ex vivo or in vitro and subsequently the immune effector cells may be administered to a subject in need of treatment, or immune effector cells may be engineered in vivo in a subject in need of treatment.
Patent AU-2020427309-A1 (AU)
Title: Solar panel and rail with edge connectors
Inventor: YOUNG JAMES
IPC: F24S25/35
Filed: 2020-02-07
Abstract: Solar panels (1) in Figs. 1-3, including crystal solar panels and thin film solar panels, which at least at edges of two opposite sides (4, 5), have frames (6,7), for use in fixed tilt solar system (Fig. 2) as well as use in tracking solar system (Fig. 3), are provided with coupling parts (8,9,16,26) in Figs. 4A, 5A, 6, 8, 11,13,16-206, together with rails (2) in Figs. 6,8,11,13-15,20,23, are also provided with coupling parts (10,11,15, 25), cooperating with each other, substantially in the form of tongue (15, 25) and groove (8,16,26), wherein the coupling parts are provided with integrated mechanical locking elements (12, 28, 37) which prevent the drifting or separating apart of coupled solar panel and rail in direction perpendicular to the solar panel surface and parallel to the solar panel surface. Furthermore the coupled tongue and groove are balanced by a set of forces in Fig. 8, Fig. 25, and integrated to support each other, and to support solar panel with combined mechanical strength, which provide opportunities to reduce materials usage, reduce dimensions, reduce packaging materials, reduce shipping cost, reduce installation time, as well as limiting installer error and other benefits.
Patent AU-2020430096-A1 (AU)
Title: Natural enhanced geothermal system using a hot sedimentary aquifer
Inventor: MARSH BRUCE D
IPC: F24T10/15
Filed: 2020-07-23
Abstract: A natural enhanced geothermal system (NAT-EGS) that uses a hot sedimentary aquifer (HSA) is disclosed. An example method may include pumping, via an extraction well, heated water from an extraction depth of a HSA, wherein the HSA satisfies a threshold geothermal characteristic. The example method may include extracting, via an energy conversion unit, heat from the heated water to capture energy, resulting in cooled water. The example method may include injecting, via an injection well, the cooled water at an injection depth of the HSA, wherein the injection depth is deeper than the extraction depth.
Patent AU-2020476229-A1 (AU)
Title: System for electrically feeding at least one electrically powered vehicle
Inventor: ASPLUND GUNNAR
IPC: B60L5/16
Filed: 2020-11-05
Abstract: System for electrically feeding electrically powered vehicles comprising at least one suspended elongated slotted element having electric conductor(s) arranged in slot(s) and at least one current collector co-acting with the slotted element. The current collector(s) comprises contact element(s) and collector arm(s) supporting the contact element(s) at its first end and is adapted to connect to an electrically powered vehicle with its second end. The collector arm(s) is formed by at least two serially arranged arm segments. A first arm segment is provided with forcing means arranged to, when the first arm segment is within a working distance from the slotted element, provide a force towards the slotted element such that the contact element connects with the corresponding electric conductor. The second arm segment is provided with at least one actuator acting on the second arm segment to displace the first arm segment to a position within the working distance.
Patent AU-2021200359-A1 (AU)
Title: Patient interface and headgear
Inventor: SMITH DANIEL JOHN
IPC: A62B18/00
Filed: 2021-01-20
Abstract: A mask assembly comprising a gases cavity having an interior surface, a seal for contacting a 
wearer's face to substantially seal said cavity, a plenum space at least partially defined by a partition 
wall located within said gases space and in fluid communication with a gases entry port for receiving 
gases, a diffuser port outlet through which gases can flow from the plenum space to the gases 
cavity, and wherein the diffuser port outlet is at least partially defined by a perimeter portion of said 
wall; wherein the diffuser port outlet and the perimeter portion of said wall are configured to diffuse 
breathing gases approximately tangential to a wearers facial surface.  
Fig 24
WO 2011/077254 PCT/IB2010/003466 
2/23 
200 
262 
----N 102 
220 
9 
202 PIC. 2 
252 20,,,,, 
222 
200 
202 
2.& 
2J9 
252 
2J6' 
2,514' 
229 '-20,5( 
2J9 
2,4'0
Patent AU-2021200855-A1 (AU)
Title: Method and system for preparing and/or caring for a medical or dental instrument
Inventor: GALLUSEDER FLORIAN
IPC: A61B90/70
Filed: 2021-02-10
Abstract: A method for preparing and/or caring for a medical or dental instrument is defined in that the 
instrument jointly with a connection adapter is first connected to a first preparation and/or care device 
and subsequently to a second preparation and/or care device. Furthermore, a coupling device is 
described which is configured to connect a preparation and/or care device for a medical or dental 
instrument to a connection adapter.
1/5 
100 
FIG. 1 A 
3 
5 5 5 
1210 
34 
50 51 
100 
FIG.B 1 
1 ~2 1 
30 5 ,4-51 
50 
100 
FIG. IC 
1 
2; 
14 
12 A.-- 13 
4-10 
50
Patent AU-2021215194-A1 (AU)
Title: Apparatus and method for transfer of cryogenic fluids – materials substitution
Inventor: PRADHAN VIJAY RAMESHCHANDRA
IPC: F17C6/00
Filed: 2021-08-11
Abstract: An apparatus for transferring a cryogenic fluid, including a subsea pipeline for 
loading cryogenic fluids from an onshore source to an offshore terminal, wherein the subsea 
pipeline includes a pipe formed of a material having a low coefficient of thermal expansion.
Patent AU-2021227681-A1 (AU)
Title: Porous medical device and methods of use
Inventor: BURKE MARTIN
IPC: A61M31/00
Filed: 2021-02-25
Abstract: A medical system including a tube defining a lumen, a porous body connected to a distal end of the tube to be advanced to a target site within a subject. The porous body defines a plurality of openings, the plurality of openings are in fluid connection with the lumen, the porous body includes a first material and a second material, and the second material elutes from the porous body in the subject.